C-Peptide Is Independently Associated with an Increased Risk of Coronary Artery Disease in T2DM Subjects: A Cross-Sectional Study.

Abstract

OBJECTIVE:

C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitus (T2DM) patients, whereas its role in coronary artery disease (CAD) has not been clarified, especially in diabetics with differing body mass indices (BMIs).

DESIGN AND METHODS:

This cross-sectional study included 501 patients with T2DM. First, all subjects were divided into the following two groups: CAD and non-CAD. Then, binary logistic regression was used to determine the risk factors for CAD for all patients. To clarify the role of obesity, we re-divided all subjects into two additional groups (obese and non-obese) based on BMI. Finally, binary logistic regression was used to determine the risk factors for CAD for each weight group.

RESULTS:

The patients with CAD showed a higher BMI and fasting C-peptide level in addition to an increased prevalence of traditional risk factors for CAD, such as hypertension, insulin resistance, higher cholesterol, cysteine-C (Cys-C) and lower estimated glomerular filtration rate (eGFR). Logistic regression analysis showed that fasting C-peptide (OR=1.513, p=0.005), insulin treatment (OR=1.832, p=0.027) hypertension (OR=1.987, p=0.016) and hyperlipidemia (OR=4.159, p<0.001) significantly increased the risk of clinical CAD in the T2DM patients independent of age, gender, diabetes duration, smoking and alcohol statuses, fasting insulin and glucose, hypoglycemic episodes, UA and eGFR. Additionally, in both of the obese (OR=1.488, p=0.049) and non-obese (OR=1.686, p=0.037) DM groups, C-peptide was associated with an increased risk of CAD after multiple adjustments.

CONCLUSIONS:

C-peptide is associated with an increased CAD risk in T2DM patients, no matter whether they are obese or not.

• Authors: Lingshu Wang, Peng Lin, Aixia Ma, Huizhen Zheng, Kexin Wang, Wenjuan Li, Chuan Wang, Ruxing Zhao, Kai Liang, Fuqiang Liu, Xinguo Hou, Jun Song, Yiran Lu, Ping Zhu, Yu Sun, Li Chen
• Journal: PloS one (PLoS One) Vol. 10 Issue 6 Pg. e0127112 ( 2015) ISSN: 1932-6203 [Electronic] United States
• PMID: 26098780 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• C-Peptide

Topics

• Body Mass Index
• C-Peptide (blood)
• Coronary Artery Disease (blood, epidemiology)
• Cross-Sectional Studies
• Diabetes Mellitus, Type 2 (blood)
• Humans
• Hyperlipidemias (physiopathology)
• Hypertension (physiopathology)
• Insulin Resistance (physiology)
• Logistic Models
• Obesity (pathology)
• Risk Factors